At Novosound, we're pioneering thin-film piezoelectric ultrasound sensor technology — a platform that makes ultrasound sensing wearable-ready, scalable, and cost-effective in ways conventional PZT ceramic transducers can't match. Our flagship application, cuff-less blood pressure monitoring, directly images the radial artery wall rather than relying on proxy signals like PPG or oscillometry, and we're pursuing simultaneous FDA 510(k) and EU MDR clearance to bring it to market as a regulated medical device.
But the underlying sensor platform extends well beyond blood pressure. Our thin-film manufacturing process is designed for mass production at a fraction of the cost of traditional ultrasound sensors, opening up applications across wellness wearables, cardiovascular diagnostics, and industrial sensing — anywhere precise, miniaturised, low-cost ultrasound has previously been out of reach. We work closely with clinical advisors, manufacturing partners, and investors to move this technology from lab-validated performance to real-world deployment, with a manufacturing base in Paisley and a growing IP portfolio protecting our core sensor architecture.
Our goal is to make advanced ultrasound sensing as ubiquitous and affordable as the technologies it's replacing — bringing medical-grade precision to everyday devices.
Social media
Areas of activity
Area of activity
AI & Machine Learning in HealthcareEarly Stage DiagnosticsHealth Data & Predictive AnalysisManagement of Chronic ConditionsReducing Pressure in Emergency CareRemote Patient Diagnostics & Monitoring
Additional questions
Which of the four UNITE Challenges does your organization tackle?
Deep-Tech Innovation for Equal HealthDigital Innovation for more personalised and human centric remote care
Novosound's enabling ultrasound sensor brings cuff-less, clinical-grade blood pressure monitoring to mobility-limited, rural and underserved populations. Seeking a system integrator and research partner to build EquiCardia with us.